New Zealand markets close in 2 hours 46 minutes

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
80.76+1.21 (+1.52%)
At close: 04:00PM EDT
81.00 +0.24 (+0.30%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.12B
Enterprise value 48.59B
Trailing P/E 33.09
Forward P/E 32.47
PEG ratio (5-yr expected) 4.52
Price/sales (ttm)9.36
Price/book (mrq)8.46
Enterprise value/revenue 9.03
Enterprise value/EBITDA 27.16

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-29.24%
S&P500 52-week change 3-13.21%
52-week high 3131.10
52-week low 367.13
50-day moving average 378.64
200-day moving average 384.78

Share statistics

Avg vol (3-month) 33.57M
Avg vol (10-day) 34.42M
Shares outstanding 5608.31M
Implied shares outstanding 6N/A
Float 8602.8M
% held by insiders 10.83%
% held by institutions 186.99%
Shares short (14 Mar 2023) 416.94M
Short ratio (14 Mar 2023) 44.31
Short % of float (14 Mar 2023) 42.81%
Short % of shares outstanding (14 Mar 2023) 42.78%
Shares short (prior month 14 Feb 2023) 411.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 331 May 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 28.28%
Operating margin (ttm)33.29%

Management effectiveness

Return on assets (ttm)13.34%
Return on equity (ttm)26.14%

Income statement

Revenue (ttm)5.38B
Revenue per share (ttm)8.69
Quarterly revenue growth (yoy)1.40%
Gross profit (ttm)4.3B
Net income avi to common (ttm)1.52B
Diluted EPS (ttm)2.43
Quarterly earnings growth (yoy)18.80%

Balance sheet

Total cash (mrq)1.22B
Total cash per share (mrq)2
Total debt (mrq)691.3M
Total debt/equity (mrq)11.90
Current ratio (mrq)3.03
Book value per share (mrq)9.55

Cash flow statement

Operating cash flow (ttm)1.22B
Levered free cash flow (ttm)933.04M